Decision-making for termination of pregnancy following non-invasive prenatal testing: a qualitative exploration of french, english and German healthcare professionals’ perceptions and concerns
Adeline Perrot, Hilary Bowman-Smart, Tamar Nov-Klaiman, Ruth Horn

TL;DR
This study explores how healthcare professionals in France, England, and Germany perceive and address concerns about decisions to terminate pregnancies based on non-invasive prenatal testing results.
Contribution
The paper provides new insights into healthcare professionals' ethical concerns regarding informed decision-making in pregnancy termination after non-invasive prenatal testing.
Findings
Healthcare professionals worry that women may make uninformed decisions about termination based solely on NIPT results.
Professionals are concerned about biased or uninformed perceptions of genetic conditions like Down’s Syndrome influencing decisions.
There is a tension between respecting autonomy and ensuring adequate counseling about NIPT implications.
Abstract
Non-invasive prenatal testing (NIPT) is offered in the French, English and German public healthcare systems for fetal aneuploidy screening from a relatively early stage of pregnancy (around 10–12 weeks of gestation). Results from NIPT can be used to inform decisions about subsequent diagnostic procedures, and pregnancy management, which may include options for termination of pregnancy (TOP). Since NIPT is a screening test and not diagnostic, clinical guidelines recommend confirmation through an invasive procedure. Across the three countries, healthcare professionals (HCPs) expressed concerns that women may make uninformed decisions around TOP, in the sense of not being fully informed either regarding the test performance or regarding the fetal condition. This paper draws on a comprehensive literature review, and data from a comparative study including 58 semi-structured interviews with…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsPrenatal Screening and Diagnostics · BRCA gene mutations in cancer · Fetal and Pediatric Neurological Disorders
